Anemia Clinical Trial
To estimate the risk of death for patients with different pre- and post-operative hemoglobin levels who do not receive blood transfusions and to derive a multivariate model using clinical information available pre-operatively that would predict the risk of death post-operatively.
BACKGROUND:
The AIDS epidemic has focused considerable attention on the risks associated with blood
transfusions. Perhaps of more importance, hemolytic transfusion reactions and
post-transfusion non-A non-B hepatitis continue to be significant concerns. However,
guidelines for blood transfusions in the surgical patient vary considerably in the medical
literature. Some recent texts stress the need to consider factors such as patient's age,
surgical procedure, co-morbid illness, predicted blood loss, and cause of the anemia, as
well as the hemoglobin level. Nonetheless, in practice many surgeons still adhere to the
10g/dl threshold for transfusion. The lack of consensus guidelines can probably be
attributed to the dearth of studies exploring the indications for transfusion. The few
studies which have examined this question are limited because they fail to analyze subsets
of patients by age, co-morbid illness, or blood loss. The need to develop peri-operative
transfusion guidelines based on multivariate analysis, therefore decreasing the frequency of
unnecessary transfusions resulting from the common use of a hemoglobin threshold, is
especially important in light of the hazards and costs associated with blood transfusions.
Jehovah's Witnesses were chosen as the study population because they decline blood
transfusion for religious reasons.
DESIGN NARRATIVE:
The retrospective case-control study explored the possible associations between
peri-operative anemia and post-operative mortality status. Cases were defined as those who
died within 30 days of the operative procedure and controls as all those who survived. There
were approximately eight controls per case. Participating surgeons who operated on Jehovah's
Witness patients within the preceeding five years provide a list of patients. Charts of
patients were reviewed to determine if any died within 30 days of surgery. If the patient
was discharged prior to 30 days postoperatively, then the National Death Index was used to
assess the patient's status 30 days after surgery. The incidence of post-operative death,
with 95 percent confidence levels, was calculated for strata of pre- and post-operative
hemoglobin levels and operative blood loss. The death rate was calculated after stratifying
the patients based on status with regard to co-morbid diseases or other possible risk
factors.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 |